BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1310785)

  • 1. Use of suppressor analysis to identify DNA polymerase mutations in herpes simplex virus which affect deoxynucleoside triphosphate substrate specificity.
    Wang YS; Woodward S; Hall JD
    J Virol; 1992 Mar; 66(3):1814-6. PubMed ID: 1310785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.
    Tsurumi T; Maeno K; Nishiyama Y
    J Virol; 1987 Feb; 61(2):388-94. PubMed ID: 3027369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.
    Hall JD; Woodward S
    J Virol; 1989 Jun; 63(6):2874-6. PubMed ID: 2542598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
    Matthews JT; Carroll RD; Stevens JT; Haffey ML
    J Virol; 1989 Nov; 63(11):4913-8. PubMed ID: 2552170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin.
    Coen DM; Furman PA; Aschman DP; Schaffer PA
    Nucleic Acids Res; 1983 Aug; 11(15):5287-97. PubMed ID: 6308578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the herpes simplex virus DNA polymerase gene.
    Purifoy DJ; Lewis RB; Powell KL
    Nature; 1977 Oct; 269(5629):621-3. PubMed ID: 199849
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain.
    Gibbs JS; Chiou HC; Hall JD; Mount DW; Retondo MJ; Weller SK; Coen DM
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7969-73. PubMed ID: 2999787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM; Furman PA; Gelep PT; Schaffer PA
    J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.
    Taddie JA; Traktman P
    J Virol; 1993 Jul; 67(7):4323-36. PubMed ID: 8389930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.
    Coen DM; Aschman DP; Gelep PT; Retondo MJ; Weller SK; Schaffer PA
    J Virol; 1984 Jan; 49(1):236-47. PubMed ID: 6317891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleic acid polymerase of wild-type and phosphonoacetic acid-resistant mutant of herpes simplex virus.
    Fridlender B; Chejanovsky N; Becker Y
    Antimicrob Agents Chemother; 1978 Jan; 13(1):124-7. PubMed ID: 204249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors.
    Chiou HC; Weller SK; Coen DM
    Virology; 1985 Sep; 145(2):213-26. PubMed ID: 2992151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB; Ruffner KL; Coen DM
    J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of herpes simplex virus DNA polymerase by purine ribonucleoside monophosphates.
    Frank KB; Cheng YC
    J Biol Chem; 1986 Feb; 261(4):1510-3. PubMed ID: 3003073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Frank KB; Cheng YC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.